Akèy › Kasinòm selil renn metastatik ak selil klè
Etid klinik pou Kasinòm selil renn metastatik ak selil klè ap rekrite nan Etazini
17 etid pou Kasinòm selil renn metastatik ak selil klè ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Baldwin Park, CA7 etid
- Dallas, TX5 etid
- Nashville, TN5 etid
- New York City, NY5 etid
- Rochester, MN4 etid
- Waukegan, IL4 etid
- St. Louis, MO4 etid
- Phoenix, AZ3 etid
- San Diego, CA3 etid
- Orlando, FL3 etid
- Omaha, NE3 etid
- Cleveland, OH3 etid
- Jacksonville, FL3 etid
- Irvine, CA3 etid
- Boston, MA3 etid
- Portland, OR3 etid
- Houston, TX3 etid
- Queens, NY3 etid
- Philadelphia, PA3 etid
- Ann Arbor, MI3 etid
- San Francisco, CA3 etid
Pa eta
- Arizona4 etid
- Arkansas3 etid
- Florid4 etid
- Illinois5 etid
- Kalifòni9 etid
- Massachusetts4 etid
- Michigan4 etid
- Minnesota5 etid
- Missouri4 etid
- Nebraska3 etid
- New Jersey3 etid
- New York6 etid
- Ohio3 etid
- Oregon3 etid
- Pennsylvania4 etid
- South Carolina4 etid
- Tennessee6 etid
- Texas6 etid
- Virginia3 etid
- Washington3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07011719Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma
Ap rekriteFaz 1
Laj 18 a 100 · Tout sèks · Mizajou Sep 25, 2026 · NCT07748988Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07227415Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT05361720A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT07195682Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT07300241Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT06866262Effects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC)
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT07179770Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 28, 2026 · NCT05263050Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT07043608Imaging of Solid Tumors Using 18F-TRX
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2026 · NCT06942104Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 16, 2026 · NCT07128680Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT07383441VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 5, 2026 · NCT07510334Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 12, 2026 · NCT06349642Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT04510597CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou May 30, 2024 · NCT06399419Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.